Acarbose
Norfloxacin may increase the hypoglycemic activities of Acarbose.
Aceclofenac
Aceclofenac may increase the neuroexcitatory activities of Norfloxacin.
Acemetacin
Acemetacin may increase the neuroexcitatory activities of Norfloxacin.
Advertisement
Acenocoumarol
Norfloxacin may increase the anticoagulant activities of Acenocoumarol.
Acetyl salicylate
Acetylsalicylic acid may increase the neuroexcitatory activities of Norfloxacin.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Norfloxacin.
Advertisement
Adapalene
Adapalene may increase the neuroexcitatory activities of Norfloxacin.
Albiglutide
Norfloxacin may increase the hypoglycemic activities of Albiglutide.
Alclometasone
The risk or severity of adverse effects can be increased when Alclometasone is combined with Norfloxacin.
Advertisement
Aldosterone
The risk or severity of adverse effects can be increased when Aldosterone is combined with Norfloxacin.
Alminoprofen
Alminoprofen may increase the neuroexcitatory activities of Norfloxacin.
Alogliptin
Norfloxacin may increase the hypoglycemic activities of Alogliptin.
Aluminum
Aluminium can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
AMBROXOL ACEFYLLINATE
The metabolism of Ambroxol acefyllinate can be decreased when combined with Norfloxacin.
Ambroxol-Theophylline-7-Acetate
The metabolism of Ambroxol acefyllinate can be decreased when combined with Norfloxacin.
Amcinonide
The risk or severity of adverse effects can be increased when Amcinonide is combined with Norfloxacin.
Aminophylline
The metabolism of Aminophylline can be decreased when combined with Norfloxacin.
Amiodarone
Norfloxacin may increase the QTc-prolonging activities of Amiodarone.
Anagrelide
Norfloxacin may increase the QTc-prolonging activities of Anagrelide.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Norfloxacin.
Androstenedione
The risk or severity of adverse effects can be increased when Androstenedione is combined with Norfloxacin.
Antipyrine
Antipyrine may increase the neuroexcitatory activities of Norfloxacin.
Apazone
Azapropazone may increase the neuroexcitatory activities of Norfloxacin.
Apremilast
Apremilast may increase the neuroexcitatory activities of Norfloxacin.
Arsenic Trioxide
Norfloxacin may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Norfloxacin may increase the QTc-prolonging activities of Artemether.
Artesunate
The serum concentration of the active metabolites of Artesunate can be reduced when Artesunate is used in combination with Norfloxacin resulting in a loss in efficacy.
Asenapine
Norfloxacin may increase the QTc-prolonging activities of Asenapine.
Aspirin
Acetylsalicylic acid may increase the neuroexcitatory activities of Norfloxacin.
Atorvastatin
The risk or severity of adverse effects can be increased when Norfloxacin is combined with Atorvastatin.
Azelastine
Azelastine may increase the neuroexcitatory activities of Norfloxacin.
Azithromycin
Norfloxacin may increase the QTc-prolonging activities of Azithromycin.
Balsalazide
Balsalazide may increase the neuroexcitatory activities of Norfloxacin.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Norfloxacin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Norfloxacin.
Bedaquiline
Norfloxacin may increase the QTc-prolonging activities of Bedaquiline.
Benzydamine
Benzydamine may increase the neuroexcitatory activities of Norfloxacin.
Betamethasone
The risk or severity of adverse effects can be increased when Betamethasone is combined with Norfloxacin.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Norfloxacin.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Norfloxacin.
Bismuth Subcitrate
Bismuth Subcitrate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Norfloxacin.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Norfloxacin.
Bromfenac
Bromfenac may increase the neuroexcitatory activities of Norfloxacin.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Norfloxacin.
Budesonide
The risk or severity of adverse effects can be increased when Budesonide is combined with Norfloxacin.
Bufexamac
Bufexamac may increase the neuroexcitatory activities of Norfloxacin.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Norfloxacin.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Norfloxacin.
Caffeine
The serum concentration of Caffeine can be increased when it is combined with Norfloxacin.
Calcium Acetate
Calcium Acetate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Chloride
Calcium Chloride can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Chloride Anhydrous
Calcium Chloride can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Citrate
Calcium Citrate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Glubionate
Calcium glubionate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium gluceptate
Calcium Gluceptate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Gluconate
Calcium gluconate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Lactate
Calcium lactate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Canagliflozin
Norfloxacin may increase the hypoglycemic activities of Canagliflozin.
Canagliflozin Anhydrous
Norfloxacin may increase the hypoglycemic activities of Canagliflozin.
Carprofen
Carprofen may increase the neuroexcitatory activities of Norfloxacin.
Casein Allergenic Extract
Casein can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Celecoxib
Celecoxib may increase the neuroexcitatory activities of Norfloxacin.
Ceritinib
Norfloxacin may increase the QTc-prolonging activities of Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Norfloxacin.
Chloroquine
Chloroquine may increase the neuroexcitatory activities of Norfloxacin.
Chlorpromazine
Norfloxacin may increase the QTc-prolonging activities of Chlorpromazine.
Chlorpropamide
Norfloxacin may increase the hypoglycemic activities of Chlorpropamide.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Norfloxacin.
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Norfloxacin.
Ciprofloxacin
Norfloxacin may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Norfloxacin may increase the QTc-prolonging activities of Cisapride.
Citalopram
Norfloxacin may increase the QTc-prolonging activities of Citalopram.
Clarithromycin
Norfloxacin may increase the QTc-prolonging activities of Clarithromycin.
Clobetasol
The risk or severity of adverse effects can be increased when Clobetasol is combined with Norfloxacin.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Norfloxacin.
Clobetasone
The risk or severity of adverse effects can be increased when Clobetasone is combined with Norfloxacin.
Clocortolone
The risk or severity of adverse effects can be increased when Clocortolone is combined with Norfloxacin.
Clonixin
Clonixin may increase the neuroexcitatory activities of Norfloxacin.
Clozapine
Norfloxacin may increase the QTc-prolonging activities of Clozapine.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Norfloxacin.
Crizotinib
Norfloxacin may increase the QTc-prolonging activities of Crizotinib.
Curcumin
Curcumin may increase the neuroexcitatory activities of Norfloxacin.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Norfloxacin.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Norfloxacin.
Cyclosporine
The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.
Dapagliflozin
Norfloxacin may increase the hypoglycemic activities of Dapagliflozin.
Deflazacort
The risk or severity of adverse effects can be increased when Deflazacort is combined with Norfloxacin.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Norfloxacin.
Desonide
The risk or severity of adverse effects can be increased when Desonide is combined with Norfloxacin.
Desoximetasone
The risk or severity of adverse effects can be increased when Desoximetasone is combined with Norfloxacin.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Desoxycorticosterone acetate is combined with Norfloxacin.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Desoxycorticosterone Pivalate is combined with Norfloxacin.
Dexamethasone
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Norfloxacin.
Diclofenac
Diclofenac may increase the neuroexcitatory activities of Norfloxacin.
Dicumarol
Norfloxacin may increase the anticoagulant activities of Dicoumarol.
Didanosine
The serum concentration of Didanosine can be decreased when it is combined with Norfloxacin.
Diflorasone
The risk or severity of adverse effects can be increased when Diflorasone is combined with Norfloxacin.
Diflucortolone
The risk or severity of adverse effects can be increased when Difluocortolone is combined with Norfloxacin.
Diflunisal
Diflunisal may increase the neuroexcitatory activities of Norfloxacin.
Difluprednate
The risk or severity of adverse effects can be increased when Difluprednate is combined with Norfloxacin.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Norfloxacin.
Digoxin
Digoxin may decrease the cardiotoxic activities of Norfloxacin.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Norfloxacin.
Dipyrone
Metamizole may increase the neuroexcitatory activities of Norfloxacin.
Disopyramide
Norfloxacin may increase the QTc-prolonging activities of Disopyramide.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Norfloxacin.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Norfloxacin.
Dofetilide
Norfloxacin may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Norfloxacin may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Norfloxacin may increase the QTc-prolonging activities of Domperidone.
Dronedarone
Norfloxacin may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Norfloxacin may increase the QTc-prolonging activities of Droperidol.
Droxicam
Droxicam may increase the neuroexcitatory activities of Norfloxacin.
Dulaglutide
Norfloxacin may increase the hypoglycemic activities of Dulaglutide.
Dyphylline
The metabolism of Dyphylline can be decreased when combined with Norfloxacin.
Eliglustat
Norfloxacin may increase the QTc-prolonging activities of Eliglustat.
Empagliflozin
Norfloxacin may increase the hypoglycemic activities of Empagliflozin.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Norfloxacin.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Norfloxacin.
Erythromycin
Norfloxacin may increase the QTc-prolonging activities of Erythromycin.
Escitalopram
Norfloxacin may increase the QTc-prolonging activities of Escitalopram.
Estrone
The risk or severity of adverse effects can be increased when Estrone is combined with Norfloxacin.
Etanercept
Etanercept may increase the neuroexcitatory activities of Norfloxacin.
Etodolac
Etodolac may increase the neuroexcitatory activities of Norfloxacin.
Etofenamate
Etofenamate may increase the neuroexcitatory activities of Norfloxacin.
Etoricoxib
Etoricoxib may increase the neuroexcitatory activities of Norfloxacin.
Evening primrose oil
Evening primrose oil may increase the neuroexcitatory activities of Norfloxacin.
Exenatide
Norfloxacin may increase the hypoglycemic activities of Exenatide.
Felbinac
Felbinac may increase the neuroexcitatory activities of Norfloxacin.
Fenbufen
Fenbufen may increase the neuroexcitatory activities of Norfloxacin.
Fenoprofen
Fenoprofen may increase the neuroexcitatory activities of Norfloxacin.
Ferric Carboxymaltose
The serum concentration of Norfloxacin can be decreased when it is combined with Ferric Carboxymaltose.
Ferric Pyrophosphate
The serum concentration of Norfloxacin can be decreased when it is combined with Ferric pyrophosphate.
Ferulic Acid
Ferulic acid may increase the neuroexcitatory activities of Norfloxacin.
Flecainide
Norfloxacin may increase the QTc-prolonging activities of Flecainide.
Floctafenine
Floctafenine may increase the neuroexcitatory activities of Norfloxacin.
Fludrocortisone
The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Norfloxacin.
Fluindione
Norfloxacin may increase the anticoagulant activities of Fluindione.
Flumethasone
The risk or severity of adverse effects can be increased when Flumethasone is combined with Norfloxacin.
Flunisolide
The risk or severity of adverse effects can be increased when Flunisolide is combined with Norfloxacin.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Flunisolide is combined with Norfloxacin.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Norfloxacin.
Fluocinonide
The risk or severity of adverse effects can be increased when Fluocinonide is combined with Norfloxacin.
Fluocortolone
The risk or severity of adverse effects can be increased when Fluocortolone is combined with Norfloxacin.
Fluorometholone
The risk or severity of adverse effects can be increased when Fluorometholone is combined with Norfloxacin.
Fluoxetine
Norfloxacin may increase the QTc-prolonging activities of Fluoxetine.
Flupenthixol
Norfloxacin may increase the QTc-prolonging activities of Flupentixol.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Fluprednidene is combined with Norfloxacin.
Fluprednisolone
The risk or severity of adverse effects can be increased when Fluprednisolone is combined with Norfloxacin.
Flurandrenolide
The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Norfloxacin.
Flurbiprofen
Flurbiprofen may increase the neuroexcitatory activities of Norfloxacin.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Norfloxacin.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Norfloxacin.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Norfloxacin.
Formestane
The risk or severity of adverse effects can be increased when Formestane is combined with Norfloxacin.
Gadobenate
Norfloxacin may increase the QTc-prolonging activities of Gadobenic acid.
Gemifloxacin
Norfloxacin may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Norfloxacin may increase the QTc-prolonging activities of Gemifloxacin.
Gliclazide
Norfloxacin may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Norfloxacin may increase the hypoglycemic activities of Glimepiride.
Glipizide
Norfloxacin may increase the hypoglycemic activities of Glipizide.
Glyburide
Norfloxacin may increase the hypoglycemic activities of Glyburide.
Goserelin
Norfloxacin may increase the QTc-prolonging activities of Goserelin.
Granisetron
Norfloxacin may increase the QTc-prolonging activities of Granisetron.
Halcinonide
The risk or severity of adverse effects can be increased when Halcinonide is combined with Norfloxacin.
Halobetasol
The risk or severity of adverse effects can be increased when Ulobetasol is combined with Norfloxacin.
Haloperidol
Norfloxacin may increase the QTc-prolonging activities of Haloperidol.
Hydrocortisone
The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Norfloxacin.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Norfloxacin.
Ibuprofen
Ibuprofen may increase the neuroexcitatory activities of Norfloxacin.
Ibutilide
Norfloxacin may increase the QTc-prolonging activities of Ibutilide.
Icatibant
Icatibant may increase the neuroexcitatory activities of Norfloxacin.
Iloperidone
Norfloxacin may increase the QTc-prolonging activities of Iloperidone.
Indobufen
Indobufen may increase the neuroexcitatory activities of Norfloxacin.
Indomethacin
Indomethacin may increase the neuroexcitatory activities of Norfloxacin.
Insulin Detemir
Norfloxacin may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Norfloxacin may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Norfloxacin may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Norfloxacin may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Norfloxacin may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Norfloxacin may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Norfloxacin may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Norfloxacin may increase the hypoglycemic activities of Insulin Lispro.
Iron
The serum concentration of Norfloxacin can be decreased when it is combined with Iron.
Iron Carbonyl
The serum concentration of Norfloxacin can be decreased when it is combined with Iron.
Iron Sucrose
The serum concentration of Norfloxacin can be decreased when it is combined with Iron saccharate.
Iron-Dextran Complex
The serum concentration of Norfloxacin can be decreased when it is combined with Iron Dextran.
Kebuzone
Kebuzone may increase the neuroexcitatory activities of Norfloxacin.
Ketoprofen
Ketoprofen may increase the neuroexcitatory activities of Norfloxacin.
Ketorolac
Ketorolac may increase the neuroexcitatory activities of Norfloxacin.
Lanthanum Carbonate
The serum concentration of Norfloxacin can be decreased when it is combined with Lanthanum carbonate.
Leflunomide
Leflunomide may increase the neuroexcitatory activities of Norfloxacin.
Lenvatinib
Norfloxacin may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Norfloxacin may increase the QTc-prolonging activities of Lenvatinib.
Leuprolide
Norfloxacin may increase the QTc-prolonging activities of Leuprolide.
Levofloxacin
Norfloxacin may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Norfloxacin may increase the QTc-prolonging activities of Levofloxacin.
Limonene, (+)-
(4R)-limonene may increase the neuroexcitatory activities of Norfloxacin.
Liraglutide
Norfloxacin may increase the hypoglycemic activities of Liraglutide.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Norfloxacin.
Lopinavir
Norfloxacin may increase the QTc-prolonging activities of Lopinavir.
Lornoxicam
Lornoxicam may increase the neuroexcitatory activities of Norfloxacin.
Loteprednol
The risk or severity of adverse effects can be increased when Loteprednol is combined with Norfloxacin.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Norfloxacin.
Loxoprofen
Loxoprofen may increase the neuroexcitatory activities of Norfloxacin.
Lumefantrine
Norfloxacin may increase the QTc-prolonging activities of Lumefantrine.
Magaldrate
Magaldrate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Salicylate
The serum concentration of Norfloxacin can be decreased when it is combined with Magnesium salicylate.
Magnesium Sulfate
The serum concentration of Norfloxacin can be decreased when it is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The serum concentration of Norfloxacin can be decreased when it is combined with Magnesium sulfate.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Masoprocol
Masoprocol may increase the neuroexcitatory activities of Norfloxacin.
Mecasermin
Norfloxacin may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Norfloxacin may increase the hypoglycemic activities of Mecasermin.
Meclofenamate
Meclofenamic acid may increase the neuroexcitatory activities of Norfloxacin.
Meclofenamic Acid
Meclofenamic acid may increase the neuroexcitatory activities of Norfloxacin.
Medrysone
The risk or severity of adverse effects can be increased when Medrysone is combined with Norfloxacin.
Mefenamic Acid
Mefenamic acid may increase the neuroexcitatory activities of Norfloxacin.
Meloxicam
Meloxicam may increase the neuroexcitatory activities of Norfloxacin.
Mesalamine
Mesalazine may increase the neuroexcitatory activities of Norfloxacin.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Norfloxacin.
Metformin
Norfloxacin may increase the hypoglycemic activities of Metformin.
Methadone
Norfloxacin may increase the QTc-prolonging activities of Methadone.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Norfloxacin.
Methylprednisolone
The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Norfloxacin.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Norfloxacin.
Mifepristone
Mifepristone may increase the QTc-prolonging activities of Norfloxacin.
Miglitol
Norfloxacin may increase the hypoglycemic activities of Miglitol.
Mometasone
The risk or severity of adverse effects can be increased when Mometasone is combined with Norfloxacin.
Moxifloxacin
Norfloxacin may increase the QTc-prolonging activities of Moxifloxacin.
MYCOPHENOLATE
The serum concentration of Mycophenolic acid can be decreased when it is combined with Norfloxacin.
Mycophenolate Mofetil
Mycophenolate mofetil may increase the neuroexcitatory activities of Norfloxacin.
Mycophenolic Acid
The serum concentration of Mycophenolic acid can be decreased when it is combined with Norfloxacin.
Nabumetone
Nabumetone may increase the neuroexcitatory activities of Norfloxacin.
Naftifine
Naftifine may increase the neuroexcitatory activities of Norfloxacin.
Naproxen
Naproxen may increase the neuroexcitatory activities of Norfloxacin.
Nateglinide
Norfloxacin may increase the hypoglycemic activities of Nateglinide.
Nepafenac
Nepafenac may increase the neuroexcitatory activities of Norfloxacin.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Norfloxacin.
Niflumic Acid
Niflumic Acid may increase the neuroexcitatory activities of Norfloxacin.
Nilotinib
Norfloxacin may increase the QTc-prolonging activities of Nilotinib.
Nimesulide
Nimesulide may increase the neuroexcitatory activities of Norfloxacin.
Nitrofurantoin
The therapeutic efficacy of Norfloxacin can be decreased when used in combination with Nitrofurantoin.
NITROFURANTOIN, MACROCRYSTALS
The therapeutic efficacy of Norfloxacin can be decreased when used in combination with Nitrofurantoin.
Oenothera biennis seed extract
Evening primrose oil may increase the neuroexcitatory activities of Norfloxacin.
Ofloxacin
Norfloxacin may increase the QTc-prolonging activities of Ofloxacin.
Olopatadine
Olopatadine may increase the neuroexcitatory activities of Norfloxacin.
Olsalazine
Olsalazine may increase the neuroexcitatory activities of Norfloxacin.
Ondansetron
Norfloxacin may increase the QTc-prolonging activities of Ondansetron.
Ouabain
Ouabain may decrease the cardiotoxic activities of Norfloxacin.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Norfloxacin.
Oxaprozin
Oxaprozin may increase the neuroexcitatory activities of Norfloxacin.
Oxyphenbutazone
Oxyphenbutazone may increase the neuroexcitatory activities of Norfloxacin.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Norfloxacin.
Paliperidone
Norfloxacin may increase the QTc-prolonging activities of Paliperidone.
Panobinostat
Norfloxacin may increase the QTc-prolonging activities of Panobinostat.
Paramethasone
The risk or severity of adverse effects can be increased when Paramethasone is combined with Norfloxacin.
Parecoxib
Parecoxib may increase the neuroexcitatory activities of Norfloxacin.
Parthenolide
Parthenolide may increase the neuroexcitatory activities of Norfloxacin.
Pazopanib
Norfloxacin may increase the QTc-prolonging activities of Pazopanib.
Pentamidine
Norfloxacin may increase the QTc-prolonging activities of Pentamidine.
Perflutren
Norfloxacin may increase the QTc-prolonging activities of Perflutren.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Norfloxacin.
Phenindione
Norfloxacin may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Norfloxacin may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
Phenylbutazone may increase the neuroexcitatory activities of Norfloxacin.
Picosulfuric Acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Norfloxacin.
Pimecrolimus
Pimecrolimus may increase the neuroexcitatory activities of Norfloxacin.
Pimozide
Norfloxacin may increase the QTc-prolonging activities of Pimozide.
Pioglitazone
Norfloxacin may increase the hypoglycemic activities of Pioglitazone.
Pirfenidone
Pirfenidone may increase the neuroexcitatory activities of Norfloxacin.
Piroxicam
Piroxicam may increase the neuroexcitatory activities of Norfloxacin.
Piroxicam-Beta-Cyclodextrin
Piroxicam may increase the neuroexcitatory activities of Norfloxacin.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Norfloxacin.
Pramlintide
Norfloxacin may increase the hypoglycemic activities of Pramlintide.
Prasterone
The risk or severity of adverse effects can be increased when Prasterone is combined with Norfloxacin.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Norfloxacin.
Prednicarbate
The risk or severity of adverse effects can be increased when Prednicarbate is combined with Norfloxacin.
Prednisolone
The risk or severity of adverse effects can be increased when Prednisolone is combined with Norfloxacin.
Prednisone
The risk or severity of adverse effects can be increased when Prednisone is combined with Norfloxacin.
Pregnenolone
The risk or severity of adverse effects can be increased when Pregnenolone is combined with Norfloxacin.
Primaquine
Norfloxacin may increase the QTc-prolonging activities of Primaquine.
Probenecid
The serum concentration of Norfloxacin can be increased when it is combined with Probenecid.
Procainamide
Norfloxacin may increase the QTc-prolonging activities of Procainamide.
Promazine
Norfloxacin may increase the QTc-prolonging activities of Promazine.
Propafenone
Norfloxacin may increase the QTc-prolonging activities of Propafenone.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Norfloxacin.
Quetiapine
Norfloxacin may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Norfloxacin may increase the QTc-prolonging activities of Quetiapine.
Quinapril
Quinapril can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quinidine
Norfloxacin may increase the QTc-prolonging activities of Quinidine.
Quinine
Norfloxacin may increase the QTc-prolonging activities of Quinine.
Regular Insulin, Human
Norfloxacin may increase the hypoglycemic activities of Insulin Human.
Repaglinide
Norfloxacin may increase the hypoglycemic activities of Repaglinide.
Resveratrol
Resveratrol may increase the neuroexcitatory activities of Norfloxacin.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Norfloxacin.
Rimexolone
The risk or severity of adverse effects can be increased when Rimexolone is combined with Norfloxacin.
Rofecoxib
Rofecoxib may increase the neuroexcitatory activities of Norfloxacin.
Rosiglitazone
Norfloxacin may increase the hypoglycemic activities of Rosiglitazone.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Norfloxacin.
Salicylamide
Salicylamide may increase the neuroexcitatory activities of Norfloxacin.
Salicylic Acid
Salicylic acid may increase the neuroexcitatory activities of Norfloxacin.
Salsalate
Salsalate may increase the neuroexcitatory activities of Norfloxacin.
Saquinavir
Norfloxacin may increase the QTc-prolonging activities of Saquinavir.
Saquinavir Mesylate
Norfloxacin may increase the QTc-prolonging activities of Saquinavir.
Saxagliptin
Norfloxacin may increase the hypoglycemic activities of Saxagliptin.
Saxagliptin Anhydrous
Norfloxacin may increase the hypoglycemic activities of Saxagliptin.
Serratiopeptidase
Serrapeptase may increase the neuroexcitatory activities of Norfloxacin.
Sevelamer
Sevelamer can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Norfloxacin.
Sitagliptin
Norfloxacin may increase the hypoglycemic activities of Sitagliptin.
Sitagliptin Phosphate
Norfloxacin may increase the hypoglycemic activities of Sitagliptin.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sotalol
Norfloxacin may increase the QTc-prolonging activities of Sotalol.
Sucralfate
The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.
Sucroferric Oxyhydroxide
The serum concentration of Norfloxacin can be decreased when it is combined with Iron saccharate.
Sulfadiazine
Norfloxacin may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Norfloxacin may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfasalazine
Sulfasalazine may increase the neuroexcitatory activities of Norfloxacin.
Sulfisoxazole
Norfloxacin may increase the QTc-prolonging activities of Sulfisoxazole.
Sulindac
Sulindac may increase the neuroexcitatory activities of Norfloxacin.
Sunitinib
Norfloxacin may increase the hypoglycemic activities of Sunitinib.
Suprofen
Suprofen may increase the neuroexcitatory activities of Norfloxacin.
Telavancin
Norfloxacin may increase the QTc-prolonging activities of Telavancin.
Telithromycin
Norfloxacin may increase the QTc-prolonging activities of Telithromycin.
Tenoxicam
Tenoxicam may increase the neuroexcitatory activities of Norfloxacin.
Teriflunomide
Teriflunomide may increase the neuroexcitatory activities of Norfloxacin.
Tetrabenazine
Norfloxacin may increase the QTc-prolonging activities of Tetrabenazine.
Theophylline
The metabolism of Theophylline can be decreased when combined with Norfloxacin.
Theophylline anhydrous
The metabolism of Theophylline can be decreased when combined with Norfloxacin.
Thioridazine
Norfloxacin may increase the QTc-prolonging activities of Thioridazine.
Tiaprofenic Acid
Tiaprofenic acid may increase the neuroexcitatory activities of Norfloxacin.
Tixocortol
The risk or severity of adverse effects can be increased when Tixocortol is combined with Norfloxacin.
Tizanidine
The serum concentration of Tizanidine can be increased when it is combined with Norfloxacin.
Tolazamide
Norfloxacin may increase the hypoglycemic activities of Tolazamide.
Tolbutamide
Norfloxacin may increase the hypoglycemic activities of Tolbutamide.
Tolfenamic Acid
Tolfenamic Acid may increase the neuroexcitatory activities of Norfloxacin.
Tolmetin
Tolmetin may increase the neuroexcitatory activities of Norfloxacin.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Norfloxacin.
Toremifene
Norfloxacin may increase the QTc-prolonging activities of Toremifene.
Tranilast
Tranilast may increase the neuroexcitatory activities of Norfloxacin.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Norfloxacin.
Triamcinolone
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Norfloxacin.
Tricalcium Phosphate
Calcium Phosphate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tromethamine
Tromethamine can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Valdecoxib
Valdecoxib may increase the neuroexcitatory activities of Norfloxacin.
Vandetanib
Norfloxacin may increase the QTc-prolonging activities of Vandetanib.
Varenicline
The serum concentration of Varenicline can be increased when it is combined with Norfloxacin.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Norfloxacin.
Warfarin
Norfloxacin may increase the anticoagulant activities of Warfarin.
Zileuton
Zileuton may increase the neuroexcitatory activities of Norfloxacin.
Ziprasidone
Norfloxacin may increase the QTc-prolonging activities of Ziprasidone.
Zomepirac
Zomepirac may increase the neuroexcitatory activities of Norfloxacin.
Zuclopenthixol
Norfloxacin may increase the QTc-prolonging activities of Zuclopenthixol.
